Mechanism of Action
Addressing Unmet Needs in Heart Failure with Barostim
- Video
Despite advances in guideline-directed medical therapy, many heart failure patients continue to struggle with symptoms that limit daily life. In this video, CVRx Chief Medical Officer Dr. Philip Adamson examines the unmet needs in heart failure management, discusses the role of Barostim Baroreflex Activation Therapy as a novel neuromodulation approach, and reviews both clinical trial data and real-world evidence demonstrating improvements in heart failure symptoms, functional capacity, and quality of life.
